Melanie Bonner

516 total citations
9 papers, 249 citations indexed

About

Melanie Bonner is a scholar working on Molecular Biology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Melanie Bonner has authored 9 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Psychiatry and Mental health and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Melanie Bonner's work include Epilepsy research and treatment (4 papers), Neonatal and fetal brain pathology (3 papers) and Cystic Fibrosis Research Advances (2 papers). Melanie Bonner is often cited by papers focused on Epilepsy research and treatment (4 papers), Neonatal and fetal brain pathology (3 papers) and Cystic Fibrosis Research Advances (2 papers). Melanie Bonner collaborates with scholars based in United States and Australia. Melanie Bonner's co-authors include Mohamad A. Mikati, Carol J. Milligan, Vandana Shashi, Yong‐hui Jiang, Melody Li, David B. Goldstein, Michael P. Carboni, Rebecca C. Spillmann, Saul A. Mullen and Slavé Petrovski and has published in prestigious journals such as Annals of Neurology, Developmental Medicine & Child Neurology and Research in Developmental Disabilities.

In The Last Decade

Melanie Bonner

9 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Bonner United States 6 148 108 76 61 55 9 249
Joanne Tracey Dean Australia 3 203 1.4× 135 1.3× 119 1.6× 106 1.7× 45 0.8× 3 310
Barbara Podestà Italy 5 159 1.1× 77 0.7× 90 1.2× 52 0.9× 94 1.7× 7 252
Simona Domenica Marino Italy 9 130 0.9× 68 0.6× 82 1.1× 29 0.5× 80 1.5× 39 287
Ryuki Matsuura Japan 10 130 0.9× 72 0.7× 62 0.8× 35 0.6× 64 1.2× 47 294
Anja C. M. Sonsma Netherlands 8 208 1.4× 66 0.6× 121 1.6× 50 0.8× 105 1.9× 9 271
Catherine Shain United States 5 105 0.7× 70 0.6× 125 1.6× 36 0.6× 62 1.1× 5 233
McKenna Kelly United States 6 102 0.7× 75 0.7× 136 1.8× 39 0.6× 39 0.7× 6 226
Sinéad B. Heavin Australia 3 137 0.9× 66 0.6× 85 1.1× 45 0.7× 62 1.1× 3 196
Viola Doccini Italy 9 92 0.6× 109 1.0× 182 2.4× 58 1.0× 108 2.0× 10 317
Agnès Gautier France 7 130 0.9× 121 1.1× 136 1.8× 50 0.8× 38 0.7× 14 295

Countries citing papers authored by Melanie Bonner

Since Specialization
Citations

This map shows the geographic impact of Melanie Bonner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Bonner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Bonner more than expected).

Fields of papers citing papers by Melanie Bonner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Bonner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Bonner. The network helps show where Melanie Bonner may publish in the future.

Co-authorship network of co-authors of Melanie Bonner

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Bonner. A scholar is included among the top collaborators of Melanie Bonner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Bonner. Melanie Bonner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mueller, David M., Melanie Bonner, Arsen Hunanyan, et al.. (2021). Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations. Epilepsy & Behavior. 116. 107732–107732. 18 indexed citations
2.
Uchitel, Julie, Lyndsey Prange, Joan Jasien, et al.. (2020). Characterization of Severe and Extreme Behavioral Problems in Patients With Alternating Hemiplegia of Childhood. Pediatric Neurology. 111. 5–12. 5 indexed citations
3.
Uchitel, Julie, Lyndsey Prange, Melanie Bonner, et al.. (2020). Social impairments in alternating hemiplegia of childhood. Developmental Medicine & Child Neurology. 62(7). 820–826. 7 indexed citations
4.
Jasien, Joan, Melanie Bonner, Lyndsey Prange, et al.. (2018). Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood. Developmental Medicine & Child Neurology. 61(5). 547–554. 25 indexed citations
5.
Weiss, Erica, David Masur, Shlomo Shinnar, et al.. (2016). Cognitive functioning one month and one year following febrile status epilepticus. Epilepsy & Behavior. 64(Pt A). 283–288. 31 indexed citations
6.
Mikati, Mohamad A., Yong‐hui Jiang, Michael P. Carboni, et al.. (2015). Quinidine in the treatment ofKCNT1‐positive epilepsies. Annals of Neurology. 78(6). 995–999. 138 indexed citations
7.
Eack, Shaun M., Stephen R. Hooper, Matcheri S. Keshavan, et al.. (2013). Feasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome. Research in Developmental Disabilities. 34(9). 2606–2613. 18 indexed citations
8.
Serafini, Sandra, Jordan Komisarow, William B. Gallentine, et al.. (2013). Reorganization and Stability for Motor and Language Areas Using Cortical Stimulation: Case Example and Review of the Literature. Brain Sciences. 3(4). 1597–1614. 4 indexed citations
9.
McIvor, Andrew, et al.. (1992). Risk of Second-Hand Exposure to Aerosol Pentamidine. Journal of Aerosol Medicine. 5(1). 11–17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026